Study Stopped
Study redesigned to be a data-only cohort study and not a clinical trial prior to any patient recruitment activities.
Evaluation of the Achieving Depression and Anxiety Patient Centered Treatment (ADAPT) Program
ADAPT
Evaluating the Implementation and Outcomes of the Achieving Depression and Anxiety Patient Centered Treatment (ADAPT) Collaborative Care Program in A Large, Integrated Healthcare System: A Mixed Methods Observational Study Protocol
1 other identifier
observational
N/A
1 country
1
Brief Summary
Depression and anxiety are increasingly common conditions for which primary care providers (PCPs) serve as the initial healthcare contact for most patients. Comorbid depression and anxiety result in higher costs, and treatment as usual, which is referrals to specialty psychiatric care, often contribute to delays in care. Collaborative psychiatric care is an evidence-based strategy to increase mental healthcare access while reducing costs. ADAPT is a novel collaborative care model. By using technology-driven appointments with providers, ADAPT increases access to mental healthcare, and reduces member wait times. This mixed methods study will assess implementation measures of the ADAPT program and the components of ADAPT related to patient mental health improvement compared to specialty mental health care. The hypothesis is that: ADAPT program will have good program reach and efficacy. We will examine program implementation and maintenance. Further, the study looks to uncover member and program characteristics that are associated with depression and anxiety remission and care utilization.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Apr 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2019
CompletedFirst Submitted
Initial submission to the registry
March 29, 2021
CompletedFirst Posted
Study publicly available on registry
April 9, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedMarch 2, 2023
February 1, 2023
3.8 years
March 29, 2021
February 28, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient reach
Examine and compare patients eligible and enrolled in ADAPT versus those eligible but not enrolled in ADAPT
through study completion, 2 years
Secondary Outcomes (14)
Member characteristics associated with depression remission
baseline, 3 and 6 months
Member characteristics associated with anxiety remission
baseline, 3 and 6 months
Efficacy: Patient therapy engagement
baseline, 3 and 6 months
Efficacy: Patient medication provider engagement
baseline, 3 and 6 months
Efficacy: Patient medication engagement
baseline, 3 and 6 months
- +9 more secondary outcomes
Study Arms (2)
Control
Patients receiving referral to specialty mental healthcare
ADAPT
ADAPT
Interventions
The Achieving Depression and Anxiety Patient Centered Treatment (ADAPT) Program is a novel collaborative psychiatric care model that is designed to unburden PCPs and psychiatrists, increase access to quality specialty mental healthcare for Kaiser Permanente members, and improve patient depression and anxiety treatment outcomes by utilizing technology-driven appointments. This program uses principles of collaborative care, including patient-centered care, population-based care, evidence-based care, measurement-based treatment to target, and accountable care.
Eligibility Criteria
Kaiser Permanente Northern California adult members who screen positive for depression or anxiety in primary care and are referred to treatment.
You may qualify if:
- Adult Outcomes Questionnaire (AOQ) score between 10-30
- English-Speaking
You may not qualify if:
- High risk for suicide defined by answer to question 9 on PHQ-9 of 1 or more
- Diagnosis of bipolar disorder
- Diagnosis of a psychotic disorder
- Dementia diagnosis
- Active substance use disorder diagnosis
- Current hospice
- Current home-based palliative care
- Residing in a skilled nursing facility
- Residing in an assisted living facility
- Non-Kaiser Permanente Member
- Established psychiatric care outside of Kaiser Permanente
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kaiser Permanente Northern California Division of Research
Oakland, California, 94612, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kathryn K Erickson-Ridout, MD PhD
Kaiser Permanente
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 29, 2021
First Posted
April 9, 2021
Study Start
April 1, 2019
Primary Completion
December 31, 2022
Study Completion
December 31, 2022
Last Updated
March 2, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share